Successful start for CATALIS
October 25, 2017
|The action plan proposed for CATALIS marks a milestone for our sector, as it is the fruit of numerous discussions with all life science stakeholders.|
CATALIS presented its five-year plan to their partners’ that will set in motion the initiative announced in the Quebec government’s Québec Life Sciences Strategy. The mission of CATALIS Quebec Clinical Trials, formerly known as the Early Stage Clinical Trials (ESCT) initiative, is to make Quebec a globally recognized hub for early-stage clinical research.
The collaboration between public and private organizations will be guided by the five strategic elements of the 2017‑2021 action plan, namely promoting operational excellence in our hospitals, the medical leadership of Quebec, networking and coordination of life sciences stakeholders, patient involvement, and innovation in early stage clinical research. These strategies are translated into concrete actions targeting, among other things, the implementation of a performance qualification for research ethics boards, and the adoption of standardized contracts to be used by all member hospitals.
“The action plan proposed for CATALIS marks a milestone for our sector, as it is the fruit of numerous discussions with all life science stakeholders. Not only will the plan support the realization of early stage clinical trials, but it will help optimize clinical research performance as a whole in Quebec,” said Danika Laberge, General Manager of CATALIS.
“I am delighted to note the strong interest the Quebec life sciences ecosystem is showing in CATALIS,” said Dominique Anglade, Deputy Premier, Minister of Economy, Science and Innovation and Minister responsible for the Digital strategy. “Hospitals and industry alike are demonstrating a will to pool their expertise in the service of a common goal. I firmly believe that this is what will position Quebec as a key player on the world stage of early-stage clinical research.”
“The Quebec province has distinguished itself by its scientific and medical research expertise, by the diversity of its population and by the cutting-edge status of its hospitals and research centres, added Gaétan Barette Minister of Health and Social Services. I am thrilled with the idea that our population could get faster access to world leading innovating treatments deriving from CATALIS initiative.”
In fact, CATALIS’s wheels are already in motion, as it has begun (...)